<DOC>
	<DOC>NCT01102543</DOC>
	<brief_summary>The aim of Aliz√© is to describe a population of premature babies (gestational age (GA) &lt; 32 weeks) in real life situation and the management of RDS.</brief_summary>
	<brief_title>Observational Study on the Prophylactic Use of Curosurf in Neonatal Respiratory Distress Syndrome (RDS)</brief_title>
	<detailed_description>Description includes gestational age, birth clinical characteristics in particular the respiratory function, evaluation of the mother prenatal corticosteroids treatment in prophylaxis of RDS, mother medical and obstetric history, premature babies care in the delivery room with a special focus on the Curosurf use: prophylactic or curative use / other surfactant / no surfactant. A special focus is on the Prophylactic use.</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
	<mesh_term>Hyaline Membrane Disease</mesh_term>
	<mesh_term>Poractant alfa</mesh_term>
	<criteria>during the study, each neonatologist will have to include all the babies born with a gestational age &lt; 32 GA gestational age &gt; 32 GA No consent to the data collection by one of the parents</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Hours</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>pulmonary surfactant</keyword>
	<keyword>Respiratory distress syndrome</keyword>
	<keyword>Newborn</keyword>
	<keyword>prophylaxis</keyword>
</DOC>